1998
DOI: 10.1021/jm9800752
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Antitumor Activity of New Glycosides of Epipodophyllotoxin, Analogues of Etoposide, and NK 611

Abstract: A series of 3-amino- and 3-alkylamino-2-deoxy-beta-D-ribo- and beta-D-arabino-glycosides of 4'-demethylepipodophyllotoxin have been synthesized by means of an improved trimethylsilyliodide procedure for the podophyllotoxin-4'-demethylepipodophyllotoxin conversion, an efficient and high yielding synthesis of silyl glycoside donors of 3-azido-2,3-dideoxy-beta-D-ribo- and beta-D-arabino-hexopyranosides and stereoselective glycosylations. In vitro evaluation of cytotoxic effects against murine L1210 leukemia criti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0

Year Published

1999
1999
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(23 citation statements)
references
References 42 publications
0
23
0
Order By: Relevance
“…In the meantime, some of the nonsugar substituted analogs of PPT, particularly the C(4 )-N-substituted congeners of PPT, such as GL-331 (7) and NPF (8) more active than VP-16 in their inhibition of the human DNA topo II [33][34][35][36][37]. Therefore, a number of 4-substituted derivatives of PPT were synthesized and tested on human topo II inhibitory or cytotoxic activity, and some compounds showed moderate to good activity against the tested cell lines [14].…”
Section: C-ring Modifications and Sarmentioning
confidence: 99%
“…In the meantime, some of the nonsugar substituted analogs of PPT, particularly the C(4 )-N-substituted congeners of PPT, such as GL-331 (7) and NPF (8) more active than VP-16 in their inhibition of the human DNA topo II [33][34][35][36][37]. Therefore, a number of 4-substituted derivatives of PPT were synthesized and tested on human topo II inhibitory or cytotoxic activity, and some compounds showed moderate to good activity against the tested cell lines [14].…”
Section: C-ring Modifications and Sarmentioning
confidence: 99%
“…The high selectivity of TOP-53 has been attributed to its distribution into the lung and its persistance. Modification in the sugar ring resulted in the development of the agent NK-611 which is currently undergoing clinical trials [90,196,207,208], Fig. (4).…”
Section: Numbering Systems For the Cyclolignansmentioning
confidence: 99%
“…The literature reports a high number of derivatives of podophyllotoxin, substituted at 7, many of them more potent than the cyclolignans already introduced into clinical practice and also others with similar activities [20,90,182,195,206,208,[219][220][221][222][223][224][225][226][227][228].…”
Section: Structure-antineoplastic Activity Relationshipmentioning
confidence: 99%
“…There is a growing interest in exploiting lignans, and their synthetic derivatives, as potential anti-cancer agents [1], [2]. Indeed, some cytotoxic lignan derivatives have reached phase I and II clinical trials as anti-tumor agents including GP-11 [3], NK-611 [4], [5], TOP-53 [6], NPF [7], GL-331 [8]–[12]. More recently, the lignan F11782 was shown to be a novel catalytic inhibitor of topoisomerases I and II, key promoters of DNA replication [13].…”
Section: Introductionmentioning
confidence: 99%